Amelioration of Cisplatin-Induced kidney injury by Arabinogalactan based on network pharmacology and molecular docking

Amelioration of Cisplatin-Induced kidney injury by Arabinogalactan based on network pharmacology and molecular docking

Cisplatin is the most widely used anticancer chemotherapy drug at present. However, its severe nephrotoxic side effects limit the clinical application. This study aimed to investigate the potential protective mechanism of arabinogalactan (AG) on acute kidney injury (AKI) induced by cisplatin in mice...

Full description

Bibliographic Details
Main Authors: Jian-Qiang Wang, Xiang-Xiang Liu, Jun-Jie Zhang, Shuai-Zhang, Chao Jiang, Si-Wen Zheng, Zi Wang, Da-Yong Li, Wei Li, Dong-fang Shi
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:Journal of Functional Foods
Subjects:
Arabinogalactan
Network pharmacology
Molecular docking
Cisplatin
Acute kidney injury
Apoptosis
Online Access:http://www.sciencedirect.com/science/article/pii/S1756464623001044

Internet

http://www.sciencedirect.com/science/article/pii/S1756464623001044

Similar Items